Stockreport

Why DBV Technologies (ENXTPA:DBV) Is Up 11.8% After Positive Phase 3 Viaskin Peanut Patch Data [Yahoo! Finance]

DBV Technologies S.A. - American Depositary Shares  (DBVT) 
US:NASDAQ Investor Relations: dbv-technologies.com/en/investor-relations
PDF with statistically significant desensitization and a safety profile consistent with earlier studies, and the company now plans to submit a US FDA Biologics License Appli [Read more]